Objectives To determine performance in lipid measurement 3 months following initiation of
lipid therapy. 1 To determine whether all patients with an indication for a PCSK9i following …

Background: Following an acute coronary syndrome (ACS), patients are at high risk for
subsequent cardiovascular events. LDL-cholesterol lowering remains a pillar in secondary …

Introduction Lowering of low-density lipoprotein (LDL) levels is known to reduce the risk of
cardiovascular events in patients with known atherosclerotic cardiovascular disease …

Background A lipid lowering therapy (LLT) algorithm at discharge after acute myocardial
infarction (AMI) targeting an LDL-c< 55mg/dL (1.4 mmol/L) was published in 2017. We …

Abstract Funding Acknowledgements Type of funding sources: Public hospital (s). Main
funding source (s): Medical University of Vienna. Background Intensive lipid lowering after …

INTRODUCTION In 2020, the Spanish Society of Cardiology published a consensus to
improve lipid control in secondary prevention patients. This study was aimed to assess the …

Background Despite the availability of effective lipid-lowering drugs, only few high-risk
patients attain their LDL cholesterol (LDL-C) guideline-recommended risk-based goal …

Background An algorithm for has been proposed to improve LDL-lowering therapy after
acute myocardial infarction (AMI). Applicability and impact on LDL-c level at 3 months …

Methods: Four Consensus Panel meetings were held in 2022 by Cardiovascular Prevention
and Lipid Working Group to achieve consensus for potential problems and solutions in LLM …

Background The management of patients with coronary artery disease (CAD) is complex,
especially after they have been discharged from hospital after an acute coronary syndrome …